Enhancer Dysregulation

Enhancer Dysregulation is a pathogenic alteration in the activity of cis-regulatory DNA elements that control gene expression in a spatial, temporal, or cell-type-specific manner, characterized by aberrant enhancer activation or silencing that disrupts normal transcriptional programs in cancer.

37

Publications

2.2K

Citations

442

Authors

141

Institutions

Publications per year

2017–2026

25

Authors

442

  1. CA
    Christopher A. Haiman

    University of Southern California, United States

    2 publications · 71 citations

    2

    h-index

  2. YD
    Yotam Drier

    Massachusetts General Hospital, United States

    2 publications · 144 citations

    2

    h-index

  3. RS
    Ranveer Singh Jayani

    National Centre for Cell Science, India

    2 publications · 83 citations

    2

    h-index

  4. PT
    Patrick Tan

    Duke-NUS Medical School, Singapore

    2 publications · 37 citations

    2

    h-index

  5. EM
    Eugene M. Oltz

    The Ohio State University, United States

    1 publications · 92 citations

    1

    h-index

1–5 of 442

Venues

  1. Nature Communications

    6 publications · 336 citations

    6

    h-index

  2. Cell Reports

    3 publications · 294 citations

    3

    h-index

  3. Nucleic Acids Research

    2 publications · 115 citations

    2

    h-index

  4. Cancer Discovery

    2 publications · 201 citations

    2

    h-index

  5. Cancer Cell

    2 publications · 324 citations

    2

    h-index

1–5